User contributions for Kosar Doraghi

21:0621:06, 12 May 2024 diff hist +47‎ Template:KDRG ‎No edit summary
21:0421:04, 12 May 2024 diff hist +215‎ Somatrogon-ghla ‎No edit summary
20:5220:52, 12 May 2024 diff hist +13,854‎ Chronic renal failure overview ‎No edit summary current
19:3519:35, 12 May 2024 diff hist 0‎ N File:IMG 1208.jpeg ‎No edit summary current
19:3319:33, 12 May 2024 diff hist 0‎ N File:IMG 1207.jpeg ‎No edit summary current
19:3219:32, 12 May 2024 diff hist 0‎ N File:IMG 1204.jpeg ‎No edit summary current
19:3019:30, 12 May 2024 diff hist 0‎ N File:IMG 1202.jpeg ‎No edit summary current
19:2819:28, 12 May 2024 diff hist 0‎ N File:IMG 1200.jpeg ‎No edit summary current
19:2419:24, 12 May 2024 diff hist 0‎ N File:IMG 1214.jpeg ‎No edit summary current
05:3005:30, 12 May 2024 diff hist +12,476‎ N Somatrogon-ghla ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.con] |genericName=somatrogon-ghla |aOrAn=a |drugClass=human growth hormone analog |indicationType=treatment |indication=pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone |hasBlackBoxWarning=Yes |adverseReactions=injection site reactions, nasopharyngitis, headache, pyrexia, anemia, cough, v..."
05:1505:15, 12 May 2024 diff hist 0‎ N File:IMG 1198.jpeg ‎No edit summary current
05:1305:13, 12 May 2024 diff hist 0‎ N File:IMG 1215.jpeg ‎No edit summary current

21:3821:38, 8 May 2024 diff hist +174‎ Template:KDRG ‎No edit summary
21:3821:38, 8 May 2024 diff hist +11‎ EXXUA ‎No edit summary current
21:3221:32, 8 May 2024 diff hist +11,561‎ N EXXUA ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=Gepirone |aOrAn=a |drugClass=extended-release tablets |indicationType=treatment |indication=major depressive disorder (MDD) in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, nausea, insomnia, abdominal pain, and dyspepsia |blackBoxWarningTitle=WARNING: SUICIDAL THOUGHTS AND BEHAVIORS |blackBoxWarningBody=SEE FULL PRESCRIBING INFORMATION FOR..."
21:2721:27, 8 May 2024 diff hist 0‎ N File:IMG 1195.jpeg ‎No edit summary current
21:2621:26, 8 May 2024 diff hist 0‎ N File:IMG 1196.jpeg ‎No edit summary current
21:1921:19, 8 May 2024 diff hist 0‎ N File:IMG 1194.jpeg ‎No edit summary current

22:5722:57, 3 May 2024 diff hist +11,950‎ N Xacduro- sulbactam and durlobactam ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sulbactam and durlobactam |aOrAn=a |drugClass=co-packaged product containing sulbactam, a beta-lactam antibacterial and beta lactamase inhibitor, and durlobactam, a beta lactamase inhibitor, |indicationType=treatment |indication=hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP), caused by susceptible isolates of Acin..." current

15:4615:46, 1 May 2024 diff hist +15,269‎ N Nirsevimab ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=Nirsevimab |aOrAn=a |drugClass=respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor |indicationType=prevention |indication=RSV lower respiratory tract disease in: Neonates and infants born during or entering their first RSV season, and children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season |hasBlackBo..." current
15:3115:31, 1 May 2024 diff hist 0‎ N File:IMG 1185.jpeg ‎No edit summary current
15:2915:29, 1 May 2024 diff hist 0‎ N File:IMG 1187.jpeg ‎No edit summary current

23:1723:17, 24 April 2024 diff hist +5,051‎ Endocarditis overview ‎No edit summary current
23:0423:04, 24 April 2024 diff hist 0‎ N File:IMG 1177.jpeg ‎No edit summary current
22:5922:59, 24 April 2024 diff hist 0‎ N File:IMG 1176.jpeg ‎No edit summary current

04:0304:03, 21 April 2024 diff hist +198‎ BRENZAVVY- bexagliflozin ‎No edit summary current
03:4803:48, 21 April 2024 diff hist 0‎ N File:IMG 1052.jpeg ‎No edit summary current
03:4703:47, 21 April 2024 diff hist +12,083‎ N BRENZAVVY- bexagliflozin ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=BRENZAVVY- bexagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=treatment |indication=glycemic control in adults with type 2 diabetes mellitus |hasBlackBoxWarning=Yes |adverseReactions=female genital mycotic infections, urinary tract infection and increased urination |blackBoxWarningTitle=Warnings |blackBoxWarningBody=*Not re..."
03:4303:43, 21 April 2024 diff hist 0‎ N File:IMG 1050.jpeg ‎No edit summary current
03:4003:40, 21 April 2024 diff hist 0‎ N File:IMG 1051.jpeg ‎No edit summary current
03:3403:34, 21 April 2024 diff hist 0‎ N File:IMG 1049.jpeg ‎No edit summary current

20:0320:03, 19 April 2024 diff hist +129‎ Template:KDRG ‎No edit summary
19:5319:53, 19 April 2024 diff hist −69‎ Template:KDRG ‎No edit summary
16:3016:30, 19 April 2024 diff hist +8,644‎ N Sparsentan ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi[mailto:k.doraghi@yahoo.com] |genericName=sparsentan |aOrAn=an |drugClass=endothelin and angiotensin II receptor antagonist |indicationType=treatment |indication=proteinuria(reduce) in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g |hasBlackBoxWarning=Yes |adverseReactions=Hepatotoxicity, Embryo-Fetal Tox..." current
16:2416:24, 19 April 2024 diff hist 0‎ N File:IMG 1046.jpeg ‎No edit summary current
16:1416:14, 19 April 2024 diff hist 0‎ N File:IMG 1045.jpeg ‎No edit summary current
16:1116:11, 19 April 2024 diff hist 0‎ N File:IMG 1047.jpeg ‎No edit summary current
16:0516:05, 19 April 2024 diff hist 0‎ N File:IMG 1044.jpeg ‎No edit summary current

06:0106:01, 21 March 2024 diff hist +195‎ Ryzneuta ‎No edit summary current
05:5805:58, 21 March 2024 diff hist 0‎ N File:IMG 0885.jpeg ‎No edit summary current

23:0823:08, 19 March 2024 diff hist +8‎ Ryzneuta ‎No edit summary
23:0723:07, 19 March 2024 diff hist +10,751‎ N Ryzneuta ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com]] |genericName=RYZNEUTA -Efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=treatment |indication=and decrease the incidence of infection, as manifested by [febrile neutropenia], in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |h..."

Navigation menu